BR112015022821A2 - método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico - Google Patents

método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico

Info

Publication number
BR112015022821A2
BR112015022821A2 BR112015022821A BR112015022821A BR112015022821A2 BR 112015022821 A2 BR112015022821 A2 BR 112015022821A2 BR 112015022821 A BR112015022821 A BR 112015022821A BR 112015022821 A BR112015022821 A BR 112015022821A BR 112015022821 A2 BR112015022821 A2 BR 112015022821A2
Authority
BR
Brazil
Prior art keywords
renal status
individual
assay kit
diagnostic assay
assessing renal
Prior art date
Application number
BR112015022821A
Other languages
English (en)
Inventor
M Sarwal Minnie
Sigdel Tara
Original Assignee
Immucor Gti Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immucor Gti Diagnostics Inc filed Critical Immucor Gti Diagnostics Inc
Publication of BR112015022821A2 publication Critical patent/BR112015022821A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

resumo patente de invenção: "métodos e composições para avaliar status renal usando dna livre de célula de urina". a presente invenção relaciona-se a ferramentas não-invasivas e métodos para avaliar o status renal e saúde renal usando dna livre de célula de urina.
BR112015022821A 2013-03-15 2014-03-15 método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico BR112015022821A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361793427P 2013-03-15 2013-03-15
PCT/US2014/029956 WO2014145232A2 (en) 2013-03-15 2014-03-15 Methods and compositions for assessing renal status using urine cell free dna

Publications (1)

Publication Number Publication Date
BR112015022821A2 true BR112015022821A2 (pt) 2017-11-07

Family

ID=51538435

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022821A BR112015022821A2 (pt) 2013-03-15 2014-03-15 método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico

Country Status (11)

Country Link
US (1) US20160024581A1 (pt)
EP (1) EP2971135A4 (pt)
JP (1) JP2016512698A (pt)
KR (1) KR20160004265A (pt)
CN (1) CN105102634A (pt)
AU (1) AU2014233262A1 (pt)
BR (1) BR112015022821A2 (pt)
CA (1) CA2902006A1 (pt)
HK (1) HK1217733A1 (pt)
MX (1) MX2015012733A (pt)
WO (1) WO2014145232A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2572003A4 (en) 2010-05-18 2016-01-13 Natera Inc METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
CN106460070B (zh) 2014-04-21 2021-10-08 纳特拉公司 检测染色体片段中的突变和倍性
CN106795562B (zh) 2014-07-18 2022-03-25 香港中文大学 Dna混合物中的组织甲基化模式分析
WO2016071331A1 (en) 2014-11-07 2016-05-12 Basf Se Agrochemical adjuvant containing 2-oxo-1,3-dioxolan-4 carboxylates
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
WO2017020023A2 (en) * 2015-07-29 2017-02-02 Progenity, Inc. Nucleic acids and methods for detecting chromosomal abnormalities
EP3141612A1 (en) * 2015-09-10 2017-03-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Method and device for nucleic acid based diagnostic approaches including the determination of a deviant condtion, especially a health condition and/or pathogenic condition of a sample
CA3033650A1 (en) * 2016-08-17 2018-02-22 The Regents Of The University Of California A novel immunoprobe-based method to assess organ injury status through a biofluid-based cell-free dna (cfdna) assay
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
KR20230062684A (ko) * 2016-11-30 2023-05-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US11525159B2 (en) * 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
WO2020076957A1 (en) * 2018-10-09 2020-04-16 Tai Diagnostics, Inc. Cell lysis assay for cell-free dna analysis
BR112020026133A2 (pt) * 2019-01-24 2021-07-27 Illumina, Inc. métodos e sistemas para monitorar a saúde e as doenças dos órgãos
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
CN111833963A (zh) * 2019-05-07 2020-10-27 中国科学院北京基因组研究所 一种cfDNA分类方法、装置和用途
CN110452975A (zh) * 2019-06-28 2019-11-15 上海奥根诊断技术有限公司 用于检测ddcfDNA的产品在制备检测肺部感染引起的移植肾损伤和预后中的用途
CN112458162B (zh) * 2020-11-16 2023-04-18 北京迈基诺基因科技股份有限公司 器官移植ddcfDNA检测试剂和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198959A1 (en) * 2002-03-28 2003-10-23 Kurnit David M. Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
US7537889B2 (en) * 2003-09-30 2009-05-26 Life Genetics Lab, Llc. Assay for quantitation of human DNA using Alu elements
JP2010068800A (ja) * 2008-08-19 2010-04-02 Sumitomo Chemical Co Ltd Ｄｎａを定量又は検出する方法
US8574842B2 (en) * 2009-12-22 2013-11-05 The Board Of Trustees Of The Leland Stanford Junior University Direct molecular diagnosis of fetal aneuploidy
US9309565B2 (en) * 2010-05-14 2016-04-12 Life Technologies Corporation Karyotyping assay
JP2014512826A (ja) * 2011-04-25 2014-05-29 バイオ−ラド ラボラトリーズ インコーポレイテッド 核酸分析のための方法および組成物

Also Published As

Publication number Publication date
EP2971135A2 (en) 2016-01-20
JP2016512698A (ja) 2016-05-09
MX2015012733A (es) 2016-06-21
HK1217733A1 (zh) 2017-01-20
AU2014233262A1 (en) 2015-09-10
CA2902006A1 (en) 2014-09-18
CN105102634A (zh) 2015-11-25
US20160024581A1 (en) 2016-01-28
WO2014145232A3 (en) 2015-01-29
KR20160004265A (ko) 2016-01-12
WO2014145232A2 (en) 2014-09-18
EP2971135A4 (en) 2016-11-09

Similar Documents

Publication Publication Date Title
BR112015022821A2 (pt) método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico
HK1217971A1 (zh) 用於核酸分析的方法、組合物和試劑盒
BR112015008621A2 (pt) Métodos e kit de diagnóstico e/ou prognóstico in vitro microconjunto de ácidos nucleicos.
BR112014011594A2 (pt) anticorpos anti-il-36r
PL2986735T3 (pl) Sposób określania składu ilościowego komórek krwi w próbce
IL235966B (en) Aqueous compositions with a ph level of 6 containing anti-Baffr antibody without fucosylation for use in the treatment of autoimmune diseases
GB201014805D0 (en) Microfluidics based assay device
ECSP12012307A (es) Proteínas de unión a il-1
EA201590027A1 (ru) Способы детекции заболеваний или состояний
HK1201577A1 (en) Point-of care immunoassay for quantitative small analyte detection
WO2015013214A3 (en) Methods and systems for microbiome characterization, monitoring and treatment
BRPI0811503A2 (pt) Diagnótico de melanoma por análise de ácido nucleico
UY33703A (es) Anticuerpos anti-il-23
MX2015005448A (es) Metodos de terapia y diagnostico relacionados con lisil oxidasa-tipo 2 (loxl2).
BR112013020454A2 (pt) método de diagnóstico de câncer e kit para diagnóstico usando medição de atividade de célula nk
BR112014008089A2 (pt) método para diagnosticar o mal de alzheimer, uso do método, e, kit para a realização do método
BRPI0820693A2 (pt) Fotoestabilidade aumentada de avobenzona na presença de óxido de zinco usando emulsificantes à base de fosfato
BR112013030886A2 (pt) método, reagente e kit para medir hemoglobina glicada.
GB2459609A (en) Methods for allergen detection
EP2966449A4 (en) TOGETHER TO DIAGNOSE RENAL DISEASES
WO2015069883A3 (en) Oxidized fraction of extracellular dna as a biomarker of stress and methods for using the same
BR112015028651A2 (pt) composição de limpeza multiuso com baixo ph
DK2367562T3 (da) Glycanspecifikke analyseværktøjer
HK1194469A1 (zh) 白細胞測定設備及試劑盒
FR2980667B1 (fr) Labyrinthe pour tests neurologiques, par exemple chez les modeles animaux de laboratoire.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements